Loading news...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
ISRG expands in Europe after acquiring da Vinci and Ion distribution across Italy, Spain and Portugal, integrating operations to directly support customers.
Intuitive Surgical's My Intuitive+ may turn paid in 2026, adding a software-driven revenue layer as renewals begin and digital engagement scales.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories Company begins direct operations in Italy, Spain, Portugal, Malta, San Marino, and associated territories
Davis R M Inc. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 24.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 51,596 shares of the medical equipment provider's stock after buying an additional 9,982 shares during the
111 Capital lifted its holdings in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 94.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 3,542 shares of the medical equipment provider's stock after buying an additional 1,725 shares during the quarter. 111 Capital's holdings in
Dana Investment Advisors Inc. lowered its position in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 49.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,119 shares of the medical equipment provider's stock after selling 1,113 shares during the period. Dana
Artisan Partners Limited Partnership cut its position in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 19.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 103,218 shares of the medical equipment provider's stock after selling 24,170 shares during the period.
Choreo LLC decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 9.6% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,158 shares of the medical equipment provider's stock after selling 1,183 shares during the period. Choreo LLC's holdings in Intuitive
Andra AP fonden lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 97.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 32,400 shares of the medical equipment provider's stock after acquiring an additional 16,000
DNB Asset Management AS raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 25.6% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 249,861 shares of the medical equipment provider's stock after buying an additional 50,854 shares
Both ISRG and ABT closed 2025 on a strong note, but Intuitive Surgical's surging procedure growth and innovation may give it the edge for long-term gains.
Intuitive Surgical's expanding installed base of surgical robots has made it a very popular stock. More diversified competitor Medtronic also offers its own surgical robot.
Tesla is banking its future on unsupervised full self-driving technology and Optimus robots. Intuitive Surgical's da Vinci systems have been used in more than 20 million procedures.
Nvidia's bold CES 2026 push into physical AI underscores a robotics boom as funding, factory adoption and humanoid rollouts fuel a pivotal growth cycle.
ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.
Intuitive Surgical can overcome recent headwinds thanks to its robust competitive edge. The robotics-assisted surgery specialist still has significant growth avenues ahead of it.
Novo Nordisk's GLP-1 pill has reignited the competition in the GLP-1 space. But you can sidestep that drama by buying this surgical robotics pioneer.
Intuitive Surgical sees international procedures jump 23% in 2025, now 35% of total, outpacing U.S. growth and reshaping its long-term expansion strategy.